1. Home
  2. SEAT vs OMER Comparison

SEAT vs OMER Comparison

Compare SEAT & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

HOLD

Current Price

$6.27

Market Cap

79.0M

Sector

Industrials

ML Signal

HOLD

Logo Omeros Corporation

OMER

Omeros Corporation

HOLD

Current Price

$19.25

Market Cap

844.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEAT
OMER
Founded
2001
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.0M
844.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
SEAT
OMER
Price
$6.27
$19.25
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$18.06
$32.50
AVG Volume (30 Days)
46.3K
2.3M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.15
EPS
N/A
0.77
Revenue
N/A
$29,868,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.60
$233.22
P/E Ratio
N/A
$23.66
Revenue Growth
N/A
N/A
52 Week Low
$5.06
$3.94
52 Week High
$18.73
$19.65

Technical Indicators

Market Signals
Indicator
SEAT
OMER
Relative Strength Index (RSI) 38.47 77.10
Support Level $6.13 $9.12
Resistance Level $7.69 N/A
Average True Range (ATR) 0.46 0.94
MACD -0.08 0.21
Stochastic Oscillator 3.85 96.85

Price Performance

Historical Comparison
SEAT
OMER

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry, providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada, and Japan. It operates in two segments: Marketplace, which generates maximum revenue, and Resale. The Marketplace segment acts as an intermediary between ticket buyers, sellers, and partners, earning revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own, and offers internal research and development support for Skybox.

About OMER Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Share on Social Networks: